Zhitong Finance App News, China Resources Pharmaceutical (03320.HK) announced that in the first half of 2026, China Resources 39 achieved total operating revenue of 15.013 billion yuan, an increase of 1.37%; realized net profit attributable to shareholders of listed companies of 1,672 billion yuan, a year-on-year decrease of 7.90 percent; realized net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss of 1,598 billion yuan, a year-on-year decrease of 5.87 percent.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.